Poop pills vs. superbugs: new hope against Antibiotic-Resistant infections
NCT ID NCT05742074
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether transplanting healthy donor stool (fecal microbiota transplantation, or FMT) into the gut could wipe out multidrug-resistant organisms (MROs) in 83 adult carriers. The goal was to prevent future hard-to-treat infections. Participants swallowed capsules containing either donor stool or a placebo, and researchers checked rectal samples for MRO clearance after 8 and 16 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAECAL MICROBIOTA TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hvidovre Hospital, Copenhagen University
Hvidovre, Copenhagen, 2650, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.